<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Speakers | Visikol</title>
	<atom:link href="https://visikol.com/blog/tag/speakers/feed/" rel="self" type="application/rss+xml" />
	<link>https://visikol.com</link>
	<description>Advanced Drug Discovery and Bioimaging Services</description>
	<lastBuildDate>Tue, 25 Oct 2022 15:42:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>Visikol CEO To Speak at 3rd International Conference Series on 3R&#8217;s Research &#038; Progress</title>
		<link>https://visikol.com/blog/2022/10/25/visikol-ceo-to-speak-at-3rd-international-conference-series-on-3rs-research-progress/</link>
		
		<dc:creator><![CDATA[Carol Tomaszewski]]></dc:creator>
		<pubDate>Tue, 25 Oct 2022 15:42:17 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Conference]]></category>
		<category><![CDATA[Speakers]]></category>
		<guid isPermaLink="false">https://visikol.com/?p=18630</guid>

					<description><![CDATA[Visikol CEO Michael Johnson, Ph.D., will be speaking at The 3rd International Conference Series on 3R's Research &amp; Progress - Advances in Animal Models and Cutting-Edge Research in Alternatives Dr. Johnson's talk will be on "Choosing the Right Liver In Vitro Model" and can be watched on Friday, November 18, 2022. Register for  [...]]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap" style="max-width:1216.8px;margin-left: calc(-4% / 2 );margin-right: calc(-4% / 2 );"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_3 1_3 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:33.333333333333%;--awb-margin-top-large:0px;--awb-spacing-right-large:5.76%;--awb-margin-bottom-large:30px;--awb-spacing-left-large:5.76%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-image-element " style="text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);"><span class=" fusion-imageframe imageframe-none imageframe-1 hover-type-none"><img fetchpriority="high" decoding="async" width="600" height="900" alt="Michael Johnson Speaker Profile" title="Michael Johnson Speaker Profile" src="https://visikol.com/wp-content/uploads/2022/10/1666405154437.jpg" class="img-responsive wp-image-18631" srcset="https://visikol.com/wp-content/uploads/2022/10/1666405154437-200x300.jpg 200w, https://visikol.com/wp-content/uploads/2022/10/1666405154437-400x600.jpg 400w, https://visikol.com/wp-content/uploads/2022/10/1666405154437.jpg 600w" sizes="(max-width: 1024px) 100vw, (max-width: 640px) 100vw, 400px" /></span></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-flex-column fusion-flex-align-self-flex-start" style="--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.88%;--awb-margin-bottom-large:30px;--awb-spacing-left-large:2.88%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-text fusion-text-1"><h2 style="text-align: center;">Visikol CEO Michael Johnson, Ph.D., will be speaking at The 3rd International Conference Series on 3R&#8217;s Research &amp; Progress &#8211; Advances in Animal Models and Cutting-Edge Research in Alternatives</h2>
<p style="text-align: center;">Dr. Johnson&#8217;s talk will be on &#8220;Choosing the Right Liver <em>In Vitro</em> Model&#8221; and can be watched on Friday, November 18, 2022.</p>
</div><div style="text-align:center;"><a class="fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span fusion-button-default-type" target="_self" href="https://www.3radvances.com/"><span class="fusion-button-text awb-button__text awb-button__text--default">Register for FREE Here</span><i class="fa-angle-double-right fas awb-button__icon awb-button__icon--default button-icon-right" aria-hidden="true"></i></a></div></div></div></div></div>The post <a href="https://visikol.com/blog/2022/10/25/visikol-ceo-to-speak-at-3rd-international-conference-series-on-3rs-research-progress/">Visikol CEO To Speak at 3rd International Conference Series on 3R’s Research & Progress</a> first appeared on <a href="https://visikol.com">Visikol</a>.]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
